Prempro

PRECISION.T-23 PRECOSE .T-11 Pred Forte.T-25 prednisolone.T-19, T-21 prednisolone acetate . T-19, T-21, T-25 prednisolone sod phosphate. T-19, T-22, T24 prednisone.T-19, T-22 Prelone .T-21 PREMARIN.T-20 PREMPHASE .T-20 PREMPRO.T-20 prenatal vit fe fum doss fa.T-27 prenatal vits w-ca, fe, fa 1mg ; .T-27 Prenate-90 .T-27 PREVACID.T-18 PREVACID IV .T-18 PREVACID NAPRAPAC .T-18 PREVPAC.T-1 Prilosec.T-18 PRILOSEC .T-18 Primacor.T-14 PRIMSOL .T-2 Prinivil.T-15 Proamatine .T-11, T-12 probenecid.T-5 procainamide hcl .T-13 PROCAINAMIDE HCL.T-13 Procan Sr.T-13 PROCANBID .T-13 prochlorperazine maleate .T-4, T-9 PROCRIT.T-12 PROGLYCEM.T-15 PROGRAF .T-21 Prolastin .T-26 PROLEUKIN.T-7 Proloprim .T-2 promethazine hcl.T-4, T-25 PRONESTYL .T-13 propafenone hcl .T-13 Propine .T-24 propranolol hcl . T-6, T-11, T-13, T-14 propylthiouracil .T-21 PROSCAR .T-18, T-21 Prostigmin .T-10 Prostin Vr .T-20.

Vitamin c with bioflavonoids : help to strengthen blood vessels and capillary walls in the uterus, because menopause prempro. The lawsuits of twelve of these plaintiffs have been removed to a multidistrict litigation in the eastern district of arkansas – western division in prempro products liability litigation.
6 25% ; with a minor response or no change on MR imaging. Median TTP for the 13 patients who completed induction therapy was 6.5 weeks range 655 + ; . Three patients have not progressed and are still on study, one with AO 55 + weeks ; , NSCLC 8 weeks ; , PCNSL 9 weeks ; . Median survival from enrollment for those patients completing induction was 11 weeks range 655 + , 7 patients censored ; . Four of the 13 patients who completed induction, but who continued to have malignant cells in the CSF, continued on IT topotecan, off protocol. These preliminary results demonstrate that IT topotecan is relatively well tolerated, but thus far appears not to provide significant benefit over other IT therapies. The favorable response of the glioma patient, echoing the results of the phase I study, may point to a particular subset of patients in whom this therapy may provide notable benefit. Updated results will be presented. tomatous tumors had the H&E appearance of mixed gliomas with oligodendroglioma and astrocytoma, and the neuronal elements were diagnosed by immunohistochemistry ; , and one had an MRI with spectroscopy that was indicative of a LGG. Nine patients were treated within 4 months of diagnosis. Eleven patients were treated after tumor recurrence. One patient who did not have MRI evidence of tumor recurrence was treated for worsening neurologic symptoms. Four patients commenced a 5-day regimen TM 150200 mg m2 day 5 days every 28 days ; and 17 patients commenced a 42-day regimen TM 75 mg m2 day 42 days every 56 days ; . Results: Five patients demonstrated partial responses 51%100% decrease in tumor size ; . Four patients showed minor responses 25%50% decrease in tumor size ; . Five patients had stable disease less than 25% change in tumor size ; for a mean duration of 21 months range 1430 months ; . Eventually, nine patients, including two of the patients who initially had tumor shrinkage, developed progressive disease. The mean time to maximal response in patients who had partial or minor responses was 18 months range 1027 months ; . The mean time to progression among patients who progressed was 16 months range 629 months ; . Toxicities of therapy were generally minor. Two patients experienced thrombocytopenia, one requiring transfusion. No patients required Neupogen or red cell transfusions. One patient required hospitalization for Mycoplasma pneumonia in association with transfusion-dependent thrombocytopenia. Eleven patients experienced fatigue, and thirteen patients had constipation; none of these patients required cessation of therapy for these side effects. Ten patients experienced nausea, responsive to oral anti-emetics; one patient required intravenous outpatient hydration for one cycle. Shingles was noted in two patients and genital warts in one. Conclusions: Temozolomide is active in adults with LGGs, and generally well tolerated up to two years of treatment. Any impact of TM upon long-term survival for this patient population remains to be demonstrated, because about prempro. Safety data collected during the Burkina Faso study are developed hereafter. Common Adverse Events Over the course of follow up, solicited Treatment-Emergent AEs TEAEs ; were reported by 286 patients out of 375 76.3% ; in the AS AQ group and 280 out of 374 74.9% ; in the AS + AQ group. The most frequent events were coughing, rhinitis, anorexia, diarrhoea and abdominal pain. A total of 266 patients 35.5% ; experienced at least one TEAE during the study. Incidence was slightly lower in the AS AQ group: 127 patients out of 375 33.9% ; versus 139 out of 374 37.2% ; in the AS + AQ group; the difference was not statistically significant. General disorders and administration site conditions were the most common mainly fever ; , reported by 17.3% of patients in the AS AQ group and 18.4% of patients in the AS + AQ group, followed by gastro-intestinal disorders mainly diarrhoea or mucous stools ; , infections infestations, respiratory disorders and ear disorders. The proportion of patients experiencing events which were rated by the investigator as possibly or probably related to study drug was very low in both treatment groups [2.4% 9 patients ; in the AS AQ group versus 1.9% 7 patients ; in the AS + AQ group]. The main spontaneously reported adverse event possibly or probably related to study drug was somnolence, reported for 6 patients in the AS AQ group and 5 patients in the AS + AQ group. TEAEs with Non-Excludable Relationship to Study Treatment: Safety Dataset. The following views were collected: Exemption on Medical Grounds: Similar proportions of respondents were for and against basing exemption on medical grounds alone. Reasons against this were that it would be fairer to base exemption on ability to pay and that defining a list of conditions to be exempted would be highly contentious. Most were in favour of reviewing the current list of conditions with the suggestion that all terminally ill or with life-long conditions should be exempt from charges. There was a divided response on giving exemption to drugs for the treatment of the condition in question rather than all prescriptions; however it was recognized that this may be difficult to define. There was an overwhelming opposition to basing exemption on a list of drugs as this would be difficult to maintain. Affordability: Suggested changes to the prepayment certificate PPC ; system included allowing payment in instalments, restructuring and prevacid.

With confidence that current post-marketing surveillance mechanisms are able to detect such differences. The challenge of designating products as interchangeable for these populations and the implications of new bioequivalence guidelines for complicated drugs from the perspective of a provincial formulary committee will be discussed. Read more depakene depakene, an epilepsy medicine, is used to treat certain types of seizures and convulsions and prilosec, for example, prempro 625. Famvir 250mg tabs Rescriptor Activella 1-0.5mg - 28 tabs Alora 0.05mg - 8 patches Cenestin 0.3, 0.625, 0.9 & 1.25mg - 30 tabs Androderm Androgel Androxy Aygestin Danazol Delestrogen Depo-Estradiol DepoTestosterone Estratest Estratest H.S. Estrogel Norethindrone Acetate Oxandrin Premarin 2.5mg tabs Premphase Prempro Prometrium 200mg Syntest D.S. Ticlopidine 250mg - 60 tabs Warfarin Sodium 1mg - 30 tabs Warfarin Sodium 2.5mg 30 tabs Warfarin Sodium 2mg - 30 tabs Warfarin Sodium 3mg - 30 tabs Warfarin Sodium 4mg - 30 tabs Warfarin Sodium 5mg - 30 tabs Famvir 500mg tabs Retrovir Flumadine Fortovase Reyataz Sustiva. This emedtv page outlines the medications that are available for headache relief and provides details on specific medicines for migraines and cluster headaches and prinivil. WORK-UP OF ABNORMAL LIVER ENZYMES ROOM # 2 1345 1430 REPEATED 1430 1515 ; DR. KELLY KAITA, Director, Viral Hepatitis Investigative Unit, Health Sciences Centre, Winnipeg, Manitoba. No Conflict Disclosed. During this workshop, the attendees will be active participants in the workup of cases of abnormal liver enzymes. The objectives of the workshop are to refine the history taking, physical exam findings and use of laboratory testing during the workup of patients with liver disease. The participant is expected to learn limitations of many of the tests used to diagnose liver disease as well as a better understanding of new tests available for the workup of liver disease. The participant will also be active in the development of a differential diagnosis for each case.

Saetak KRIPTOGENA ORGANIZIRAJUA PNEUMONIJA IDIOPATSKA BRONHIOLITIS OBLITERANS ORGANIZIRAJUA PNEUMONIJA A. Beki, M. Mehuli, D. Krmpoti, S. Kukulj, M. Gorean i . Krianac Kriptogena organizirajua pneumonija je rijedak entitet u pulmologiji sa znakovitim klinikim, radiografskim i histolokim manifestacijama. Radiografske manifestacije, kao i ventilacijsku i respiracijsku plunu funkciju odreuju pupoljci granulacijskog tkiva u alveolama i alveolarnim hodnicima, koji se mogu vidjeti i u bronhiolama. Zato je nuna histoloka potvrda ovih promjena koje su znakovite, ali ne i specifine za kriptogenu organizirajuu pneumoniju. Kao sinonim za ovu bolest nepoznatog uzroka rabi se i izraz idiopatska primarna ; bronhiolitis obliterans organizirajua pneumonija. Postoji i sekundarna organizirajua pneumonija koja ima razliite uzroke. Cilj ovoga prikaza je upozoriti na dvije razliite manifestacije kriptogene organizirajue pneumonije: jedna je polagana, kronina, s migrirajuim upalnim infiltratima i blagom klinikom slikom, a druga akutna s tekom klinikom slikom. U oba sluaja uslijedio je dobar odgovor na terapiju kortikosteroidima, ali se je javio recidiv koji je takoer dobro reagirao na ovo lijeenje. Kljune rijei: Bronhiolitis obliterans organizirajua pneumonija dijagnostika; Bronhiolitis obliterans organizirajua pneumonija terapija and procardia.

PLACEBO.44 PLACIDYL.27 PLAN B.61 PLASMA-LYTE 148.71 PLASMA-LYTE 148 IN DEXTROSE .71 PLASMA-LYTE 56.72 PLASMA-LYTE 56 IN DEXTROSE .72 PLASMA-LYTE A PH 7.4.72 PLASMA-LYTE R .72 PLAVIX.33 PLENAXIS.20 PLEXION.40 PNEUMOVAX 23 .57 PODOCON-25 .37 podofilox.37 polocaine .37 poly iron pn forte.73 poly otic .46 polymyxin b sul trimethoprim .65 polymyxin b sulfate.17 POLY-PRED .63 polytab .72 POLY-VI-FLOR W IRON .72 PONSTEL .26 PONTOCAINE.37, 40 potassium.73 potassium acetate .73 POTASSIUM CHL NORMAL SALINE.73 potassium chl normal saline .73 potassium chloride .73 potassium gluconate.73 POTASSIUM HYDROXIDE .37 PRAMOSONE .40 PRANDIN .50 PRAVACHOL.33 PRAVIGARD PAC.33 prazosin HCl.29 PRECARE .73 PRECARE CONCEIVE.73 PRECARE PRENATAL.73 PRECEDEX .27 PRECOSE .50 PRED MILD .63 PRED-G .63 prednisolone .49 prednisolone acetate.63 prednisone .49 PREDNISONE INTENSOL .50 PREFEST .61 PREMARIN .61, 62 premasol .74 PREMESIS RX .73 PREMPHASE .61 PREMPRO .61 90. Metoprolol metoprolol lopressor lopressor images lopressor drug interactions user comments: be the first to write a comment about lopressor see also: angina pectoris , angina pectoris prophylaxis , congestive heart failure , hypertension , myocardial infarction , supraventricular tachycardia all services a-z drug list drugs & medications diseases & conditions news & articles pill identifier interactions checker drug side effects drug image search new drug approvals new drug applications fda drug alerts clinical trial results patient care notes medical encyclopedia medical dictionary medical videos - community forums for professionals drug imprint codes medical abbreviations veterinary drugs contact us news feeds advertise here recent searches magnesium elaprase zerit fortical neulasta fragmin amphadase zavesca halflytely levaquin alli viagra propecia xenical botox levitra nicotine prempro codeprex cipro bupropion avalide patanol fioricet eurax recently approved totect acam2000 somatuline depot evithrom zingo selzentry evamist calomist privigen atralin gel more and promethazine.
Richard Cauchi, Medicaid Survival Kit: 7. Pharmaceuticals, National Conference of State Legislatures, May 2002, p. 710. Richard Cauchi, Medicaid Survival Kit: 7. Pharmaceuticals, National Conference of State Legislatures, May 2002, p. 7-10, for example, prempro attorneys. Member: how can something prempro ; that comes from a natural source pregnant mare urine ; cause so many side effects and problems and propoxyphene. A 63-year-old white female with a 20year history of osteoarthritis was treated with multiple trials of nonsteroidals, which resulted in GI upset. She was placed on Celebrex 200mg po QD with a resolution of symptoms. Other medications taken simultaneously were Cholestyramine, Prempro, Pepcid, Lipitor, Zoloft, and Accupril. She is not allergic to sulfonamides. Approximately 2 months after initiation of Celebrex, the patient presented with right lower leg patchy erythema, pedal edema, and slight pruritis. In addition, there was some purplish discoloration combined with the edema suggestive of Henoch-Schonlein purpura. TSH, ANA, and Rheumatoid Factor were negative. Over the next two days the erythema and edema worsened and the left leg became involved. Bilateral lower leg nodose lesions evolved on the extensor surfaces of her legs. Chest X-Ray, ASO titer, ACE titer, ANCA, and ESR were all negative. Punch biopsy from the left leg revealed a reactive epidermis with benign hyperkeratosis. A perivascular mixed lymphocytic and polymorphonuclear PMN ; light infiltrate was noted around the superficial dermal vessels. In the subcutaneous fat, a heavy granulomatous mixed infiltration of giant cells, monocytes, and PMN's with toxic fibrinoid changes to small veins was noted in a septal panniculitis pattern Fig. Figure 1. Kaplan-Meier plot of unadjusted time to Medicare institutional claims for de novo heart failure HF ; International Classification of Diseases, Ninth Revision, code 428.x ; by use or nonuse of -blockers 60 days or more after the start of dialysis in patients with Medicare as the primary payer at day 60, United States Renal Data System Morbidity and Mortality Study Wave 2 cohort, excluding patients with a known diagnosis of HF. Time to de novo chronic heart failure was significantly longer for use of -blockers, P .007 by the log rank test and proventil.

Buy cheap Prempro

9; heart disease, stroke and blood clots the use of prempro or premphase may increase your chance of having a heart attack, a stroke, blood clots, a pulmonary embolus a blood clot formed in the legs or pelvis that breaks off and travels to the lungs ; , retinal thrombosis a clot in a blood vessel of the eye ; , or other blood clotting problems. This application describes the use of three related solid phase extraction SPE ; sorbents and reverse phase HPLC C18 ; for the isolation and determination of six relevant pharmaceuticals. Effectiveness is assessed via recovery and cleanliness of the extract, and peak shape and symmetry. Analysis was completed via single quadrupole MS using both electrospray ionization ESI ; and atmospheric pressure chemical ionization APCI ; modes and prozac. Accutane ace inhibitors ambien topical anesthetic creams aransep aredia asthma inhaler bextra celebrex cialis crestor dietary supplements divalproex depakote celebrex cialis crestor epogen femara fentanyl patches gadolinium ketek levitra meridia metabolife mifeprex mifaprex mobic paxil phenergan prempro procrit prozac quinine risperdal ritalin rituxan seroquel tequin trasylol tsyabri viagra vioxx zicam zoloft zometa zyprexa select a drug for more information on its dangerous side effects: free case review call toll free: 1-866-972-1500 call us toll free at 1-866-972-1500 or fill out the following form to begin your case review.
1 division of basic health sciences, emory university, emory university, ga and psilocybin and prempro, for example, prempro alternatives. Hunan Niwed Bwriadol yng Ngogledd Cymru. Dadansoddiad o Fynediadau Brys i'r Ysbyty dros gyfnod o bum mlynedd Dr. Wally Barr, Lerpwl Mae'r astudiaeth hon ar y gweill ac nid oes unrhyw broblemau. Cyflwynwyd canlyniadau i'r Gynhadledd Ryngwladol ar Hunan Niwed yng Nghaerlyr ac i'r Trydydd Cynhadledd Pan-Asia ar Iechyd Meddwl yn Beijiing, Tsieina. Dim canlyniadau wedi eu cyhoeddi eto. Anghenion gwasanaeth plant nam clyw a'u teuluoedd yng Ngogledd Cymru Dr. S. Minchom, Wrecsam Mae'r astudiaeth hon wedi'i chwblhau heb unrhyw broblemau. Cyflwynwyd canlyniadau i Grwpiau Rhieni yng Ngogledd Cymru ond nid ydynt wedi eu cyhoeddi eto. Ymarferoldeb sgrinio gwybyddol cleifion gyda strc isgaemig gan ddefnyddio batri Newroseicoleg Cychwynnol Mr. P. Hobson, Ysbyty Glan Clwyd Mae'r astudiaeth hon wedi'i chwblhau heb unrhyw broblemau. Cyflwynwyd canlyniadau i'r `Health Psychology Journal'. Farnais Duraffat Colgate Dr. S. Sandham, Ysbyty Brenhinol Alexandra Mae'r astudiaeth hon ar y gweill ac nid oes unrhyw broblemau. Dim canlyniadau wedi eu cyflwyno na'u cyhoeddi eto. Your problem but curious why dr still had you taking prempro and ranitidine.

Women and their doctors shied away from the hormones … read full story permalink comments - north jersey media group - northjersey july 19, 2007 · filed under prempro north jersey media groupnorthjersey , nj - 51 minutes ago… settled on the eve of trial a lawsuit by a terminally ill woman who blamed the company' s prempro menopause drug for her breast cancer. Estradiol tab ; Estradiol patch VIVELLE, ESTRADERM, ESCLIM ; Estropipate VIVELLE DOT ; CLIMARA PATCH ; Estrogens, conjugated PREMARIN ; Estradiol ring ESTRING ; Estrogen Progestin Conjugated estrogens medroxyprog. PREMPHASE, PREMPRO ; Norethindrone estradiol FEMHRT. Tolerated by patients studied. 108. Plaintiffs purchased Prempro for the purpose of ingesting it and. It is also used in the treatment premia premphase , prempro ; used to treat certain symptoms of menopause in women who have not had surgical removal of the uterus a hysterectomy. PREMARIN is used after menopause to reduce moderate to severe hot flashes; to treat moderate to severe dryness, itching, and burning in or around the vagina; and to help reduce a woman's chances of getting osteoporosis thin, weak bones ; . PREMPRO is used after menopause in women with a uterus to reduce moderate to severe hot flashes; to treat moderate to severe dryness, itching, and burning in or around the vagina; and to help reduce a woman's chances of getting osteoporosis thin, weak bones ; . PREMARIN and PREMPRO should be used at the lowest effective dose and for the shortest duration consistent with a woman's treatment goals and risks. If using PREMARIN or PREMPRO only to treat a woman's symptoms of vaginal dryness, consider topical therapies first. If a woman does not have symptoms, non-estrogen treatments should be carefully considered before taking PREMARIN and PREMPRO solely for the prevention of postmenopausal osteoporosis. In a clinical trial, the most commonly reported 5% ; side effects that occurred more frequently with PREMARIN were vaginitis due to yeast or other causes, vaginal bleeding, painful menstruation, and leg cramps. In a clinical trial, the most commonly reported 5% ; side effects that occurred more frequently with PREMPRO 0.45 mg 1.5 mg and PREMPRO 0.625 mg 2.5 mg were breast pain enlargement, vaginitis due to yeast or other causes, leg cramps, vaginal spotting bleeding, and painful menstruation. In a clinical trial, there was no difference in the commonly reported 5% ; side effects for women taking PREMPRO 0.3 mg 1.5 mg compared to those taking placebo and prevacid.

17. Khurshudian AV. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjogren's Syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 38-44. Perminova IS, Goidenko VS, Rudenko IV. [Experience with using reflexotherapy in treating Sjogren's syndrome]. Stomatologiia Mosk ; 1981; 60: 37-38. Blom M, Lundeberg T. Long-term followup of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis 2000; 6: 15-24. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. Sensory stimulation acupuncture ; increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides 1999; 33: 244-250. Wong RK, Jones GW, Sagar SM, Babjak AF, Whelan T. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiationinduced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 472-480. Vitolo JM, Baum BJ. The use of gene transfer for the protection and repair of salivary glands. Oral Dis 2002; 8: 183-191. O'Connell AC, Baccaglini L, Fox PC, O'Connell BC, Kenshalo D, Oweisy H, Hoque AT, Sun D, Herscher LL, Braddon VR, Delporte C, Baum BJ. Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther 1999; 6: 505-513. Joraku A, Sullivan CA, Yoo JJ, Atala A. Tissue engineering of functional salivary gland tissue. Laryngoscope 2005; 115: 244248. Aframian DJ, David R, Ben-Bassat H, Shai E, Deutsch D, Baum BJ, Palmon A. Characterization of murine autologous salivary gland graft cells: A model for use with an artificial salivary gland. Tissue Eng 2004; 10: 914-920. Fox PC. Acquired salivary dysfunction. Drugs and radiation. Ann N Y Acad Sci 1998; 842: 132-137. To order reprints of this article, contact Jill Kaletha at 866.879.9144, ext. 168 or jkaletha fostereprints.
Decreased premenstrual syndrome symptoms breast swelling tenderness, bloating ; and or hot flashes Augmented immunity and resistance to infections Improved overall health and vitality BHRT has distinct advantages over non-bio-identical or artificial hormone replacement therapy. Bio-identical hormones are by definition identical to those already found within the human body. Bio-identical hormones are therefore completely compatible within the human body and well tolerated in patients when on a monitored, medical supervised regimen by a physician ; in comparison to artificial hormone replacement or other drug therapies. Examples of bio-identical hormones that are currently in use to treat a wide variety of medical symptoms include: Human Growth Hormone Testosterone DHEA Estrogens Progesterone Melatonin Compounded bio-identical T4 and T3 ; thyroid medications While bio-identical hormones are steroids, they should not be confused with artificial anabolic steroids, whose abuse in an unsupervised environment have led to multiple reports of adverse side effects including kidney failure, etc. In fact, bio-identical hormones have proven to be superior to other well-known artificial hormones such as Premarin, Provera, Prempro, Synthroid, etc. The failure of Premarin, derived from pregnant mare horse ; urine, Prempro and Provera were well documented in the 2003 Women's Health Initiative WHI ; study where increased rates of cancer, cardiovascular events heart attacks and stroke ; , and weight gain were among the multiple adverse side effects related to the use of the Premarin, Provera or Prempro. In this day and age, it is strange to think that horse estrogens from mare urine were once considered beneficial for a woman's body and the standard of medical care. Thankfully, much better alternatives to artificial hormones are now possible because of the availability of bio-identical estrogen and progesterone today. Anti-aging medicine is essentially traditional medicine combined with the latest medical advances and technologies. BHRT is the cornerstone of Anti-Aging Medicine, with goals of restoring youthful levels of one's body's naturally occurring hormones to the optimal levels. The combination of.

Prempro side effects

7. I expect low prices on OTC medicines. Deutsch used premarin from february 1995 to july 1996, and prempro from august 1996 to april 2002, to treat her hot flashes and other symptoms of menopause.

Reference FDA 2003 ; Safety alert: FDA approves prescribing information for Postmenopausal Hormone Therapies online ; fda.gov medwatch safety 2003 prempro.

Ozone Ozone O3 ; is a water-soluble, naturally occurring gas which is a powerful oxidising agent. and very unstable, on exposure to air and water it rapidly decomposes to form oxygen. Due to this instability generation is usually at the point of use. Ozonated chiller water containing levels of aqueous ozone between 3.0 to 4.5 ppm was found by Sheldon and Brown 26 ; to be more effective at reducing microbial counts on poultry carcasses than non-ozonated water chilling. No significant carcass skin colour losses, lipid oxidation, or off flavours were found on poultry carcasses treated in this way. Both aerobic and psychrophilic counts remained lower on ozone-chilled carcasses than on those water-chilled during shelf life studies at 4.4C. Steam One treatment gaining acceptance is the use of steam. A number of processes using steam for treating meat have been devised and some used commercially with varying degrees of success. Steam at 100C has a substantially higher heat capacity than the same amount of water at that temperature. If steam is allowed to condense onto the surface of meat then it has the ability to rapidly raise the surface temperature of the meat. Direct application of steam to pork carcasses has been shown to reduce total bacterial counts by 6 log micro-organisms cm-2. However, the steam marred the appearance of the pig carcasses 27 ; . Steam can be produced under vacuum at temperatures substantially below 100C without substantially reducing its heat capacity. It has been shown to be an effective way of decontaminating poultry drumsticks and carcasses, surface temperatures of 75C for 4 minutes achieving reductions of the order of 5.5 and 3 log, respectively 28 ; . Similar reductions have been achieved using very short treatments of steam under pressure 140C for 50 ms ; . Over-heating of the meat was prevented by repeated cycles of heating and cooling 29 ; . One very attractive feature of condensing steam is its ability to penetrate cavities and condense on any cold surface. The most successful steam process yet, in terms of industrial application, has been that developed by Kansas State University together with Frigoscandia and Cargill Inc. 30 ; . Studies on this commercially available system for treating red meat carcasses have been conducted by Nutsch et al. 31, 32 ; and Phebus et al. 33 ; . Significant reductions of the order of 3.5 log-units for specific bacteria have been reported. Novel methods A whole range of more novel techniques, such as microwaves 34 ; ultra-violet UV ; light 35 ; or visible light 35 ; , have been suggested for treating produce and meats, and in some cases demonstrated to be viable alternatives. Most of these methods depend on heat to destroy the bacteria present though a number of non-thermal treatments have been proposed 36, 37 ; . High voltage pulsed electric field PEF ; treatment relies on the lethal effect of strong electric fields for the inactivation of micro-organisms and has been proposed as a potential non-thermal food preservation technique. Another non thermal technique involving the inactivation of micro-organisms by subjecting product to one or more pulses of an oscillating magnetic field. This was described in a world patent assigned to Maxwell Laboratories Inc. of San Diego, California 38 ; . The mechanism of microbial inactivation, as described by the authors, is due to effects caused to magneto-active.

© 2006-2007 Online.freehostplace.com -All Rights Reserved.